Literature DB >> 35975257

COULD PROTEINURIA PREDICT THE RENAL PROGNOSES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC NEPHROPATHY?

J L Wang1,2, Y Sun1, Y Wang1, Y Wu1, F Liu1.   

Abstract

Aims: This study investigated the relationship between proteinuria levels, clinicopathological features, and renal prognoses in Chinese patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN).
Methods: Three hundred patients with T2DM and biopsy-proven DN were enrolled. Patients were stratified by 24-h proteinuria levels: Group 1:≤1g/24h); Group 2:1-3g/24h; and Group 3:≥3g/24h. Renal outcomes were defined as having reached end-stage renal disease (ESRD). The proteinuria level's influence on the renal outcomes was evaluated using Cox regression analysis.
Results: Among subgroups stratified by proteinuria levels, systolic blood pressure, serum creatinine, BUN, cholesterol, DR and hypertension incidence, the incidences of patients who progressed to ESRD were the lowest in group 1 (P<0.05). However, eGFR, serum albumin and hemoglobin were highest in group 1. Patients with higher proteinuria levels had much lower five-year renal survival rates. Univariate analyses revealed that higher proteinuria levels were significant clinical predictors of renal prognosis (P<0.05), although they were not independent risk factors for progression to ESRD in the multivariate Cox proportional hazard analysis (P>0.05). Conclusions: The higher the level of proteinuria, the lower the 5-year renal survival rate of DN patients, but there was no significant correlation between proteinuria level and 5-year renal survival rate. Other factors in the proteinuria group may have more significant effects on the 5-year renal survival rate, such as lower baseline eGFR, serum albumin, hemoglobin and higher cholesterol, higher incidences of DR and more severe lesions. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  clinico-pathological features; diabetic nephropathy; prognoses; proteinuria

Year:  2022        PMID: 35975257      PMCID: PMC9365414          DOI: 10.4183/aeb.2022.29

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  26 in total

Review 1.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology.

Authors:  Juliana C N Chan; Vasanti Malik; Weiping Jia; Takashi Kadowaki; Chittaranjan S Yajnik; Kun-Ho Yoon; Frank B Hu
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

Review 2.  Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.

Authors:  Manjeri A Venkatachalam; Joel M Weinberg; Wilhelm Kriz; Anil K Bidani
Journal:  J Am Soc Nephrol       Date:  2015-03-25       Impact factor: 10.121

3.  Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.

Authors:  Wouter B A Eijkelkamp; Zhongxin Zhang; Giuseppe Remuzzi; Hans-Henrik Parving; Mark E Cooper; William F Keane; Shahnaz Shahinfar; Gilbert W Gleim; Matthew R Weir; Barry M Brenner; Dick de Zeeuw
Journal:  J Am Soc Nephrol       Date:  2007-04-04       Impact factor: 10.121

4.  Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.

Authors:  Li Li; Xiuhui Zhang; Zhicheng Li; Rui Zhang; Ruikun Guo; Qinghua Yin; Lichuan Yang; Rongzheng Yue; Baihai Su; Songmin Huang; Huan Xu; Cijiang He; Fang Liu
Journal:  J Diabetes Complications       Date:  2016-10-26       Impact factor: 2.852

5.  Risk of mortality associated to chronic kidney disease in patients with type 2 diabetes mellitus: a 13-year follow-up.

Authors:  José Antonio Gimeno-Orna; Yolanda Blasco-Lamarca; Belén Campos-Gutierrez; Edmundo Molinero-Herguedas; Luis Miguel Lou-Arnal; Blanca García-García
Journal:  Nefrologia       Date:  2015-07-08       Impact factor: 2.033

6.  Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

Authors:  Holly J Kramer; Quan Dong Nguyen; Gary Curhan; Chi-Yuan Hsu
Journal:  JAMA       Date:  2003-06-25       Impact factor: 56.272

7.  Improved prognosis of diabetic nephropathy in type 1 diabetes.

Authors:  Gudbjörg Andrésdóttir; Majken L Jensen; Bendix Carstensen; Hans-Henrik Parving; Peter Hovind; Tine W Hansen; Peter Rossing
Journal:  Kidney Int       Date:  2014-06-11       Impact factor: 10.612

8.  The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.

Authors:  William F Keane; Barry M Brenner; Dick de Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert Toto
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

9.  Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS).

Authors:  S Katayama; T Moriya; S Tanaka; S Tanaka; Y Yajima; H Sone; S Iimuro; Y Ohashi; Y Akanuma; N Yamada
Journal:  Diabetologia       Date:  2011-02-01       Impact factor: 10.122

10.  Standards of Medical Care in Diabetes-2017 Abridged for Primary Care Providers.

Authors: 
Journal:  Clin Diabetes       Date:  2017-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.